Prospector services will be down Thu. 3/28 from approximately 4pm - 8pm MST.

 

The Antidote: inside the world of new pharma

Book Cover
Average Rating
Author:
Publisher:
Varies, see individual formats and editions
Pub. Date:
Varies, see individual formats and editions
Description
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex's bold endurance and eventual success. The $325-billion-a-year pharmaceutical business is America's toughest and one of its most profitable. It is riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's twenty-five-year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades.
Also in This Series
More Like This
More Copies In Prospector
Loading Prospector Copies...
More Details
ISBN:
9781452699882
Reviews from GoodReads
Loading GoodReads Reviews.
Tagging
Tags:

No Tags, Be the first to tag this record!


Staff View

Grouping Information

Grouped Work ID5e330a79-d695-f68d-092d-1d0e297122b4
Grouping Titleantidote inside the world of new pharma
Grouping Authorbarry werth
Grouping Categorybook
Grouping LanguageEnglish (eng)
Last Grouping Update2023-11-28 08:57:58AM
Last Indexed2024-03-28 01:45:01AM

Solr Fields

accelerated_reader_point_value
0
accelerated_reader_reading_level
0
auth_author2
Pratt, Sean
author
Werth, Barry
author2-role
Pratt, Sean,reader
hoopla digital
author_display
Werth, Barry
display_description
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex's bold endurance and eventual success. The $325-billion-a-year pharmaceutical business is America's toughest and one of its most profitable. It is riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's twenty-five-year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades.
id
5e330a79-d695-f68d-092d-1d0e297122b4
isbn
9781452699882
last_indexed
2024-03-28T07:45:01.739Z
lexile_score
-1
literary_form
Unknown
literary_form_full
Unknown
primary_isbn
9781452699882
publishDate
2014
publisher
Tantor Media, Inc
recordtype
grouped_work
subject_facet
Biotechnology
Business
Economics
title_display
The Antidote : inside the world of new pharma
title_full
The Antidote : inside the world of new pharma [electronic resource] / Barry Werth
title_short
The Antidote
title_sub
inside the world of new pharma
topic_facet
Biotechnology
Business
Economics

Solr Details Tables

item_details

Bib IdItem IdShelf LocCall NumFormatFormat CategoryNum CopiesIs Order ItemIs eContenteContent SourceeContent URLDetailed StatusLast CheckinLocation
hoopla:MWT11412342Online Hoopla CollectionOnline HooplaeAudiobookAudio Books1falsetrueHooplahttps://www.hoopladigital.com/title/11412342?utm_source=MARC&Lid=hh4435Available Online

record_details

Bib IdFormatFormat CategoryEditionLanguagePublisherPublication DatePhysical DescriptionAbridged
hoopla:MWT11412342eAudiobookAudio BooksUnabridgedEnglishTantor Media, Inc20141 online resource (1 audio file (16hr., 27 min.)) : digital.